{"id":446847,"date":"2021-03-01T08:03:36","date_gmt":"2021-03-01T13:03:36","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=446847"},"modified":"2021-03-01T08:03:36","modified_gmt":"2021-03-01T13:03:36","slug":"aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/","title":{"rendered":"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">VANCOUVER, British Columbia, March  01, 2021  (GLOBE NEWSWIRE) &#8212; Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (\u201cAequus\u201d or the \u201cCompany\u201d), a Canadian specialty pharmaceutical company announces the commercial availability of <strong>Evolve<\/strong><sup><strong>TM<\/strong><\/sup> preservative free lubricating eye drops for dry eye care.<\/p>\n<p align=\"justify\">These premium formulations &#8211; \u2018<strong>Intensive Daily\u2019<\/strong> drops, with the gold standard 0.2% sodium hyaluronate, and the unique, triple action \u2018<strong>Intensive Gel\u2019<\/strong> drops, containing hyaluronate, carbomer 980 and glycerol &#8211; will provide soothing hydration and symptom relief for patients with dry eye disease. The products will be available exclusively for sale by eye care clinics in Canada, where patients can receive the full benefit of dry eye treatment plans when they are diagnosed, prescribed, and monitored by eye care professionals.<\/p>\n<p align=\"justify\">\u201cWe are excited to launch the Evolve line of dry eye products in Canada, as they will not only improve treatment and compliance for better patient outcomes but create an improved revenue stream for professionals who spend additional time and resources treating dry eye patients in practice,\u201d says Grant Larsen, Chief Commercial Officer for Aequus Pharmaceuticals. \u201cThis launch adds another 2 products to our growing Eye Care portfolio and represents a significant revenue opportunity for Aequus going forward.\u201d\u00a0\u00a0<\/p>\n<p align=\"justify\">The Evolve<sup>TM<\/sup> lubricating eye drops are crafted specifically for supporting optimal eye care and contain:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:left\">Preservative and phosphate free formulations<\/li>\n<li style=\"text-align:left\">A secure antimicrobial twist-cap<\/li>\n<li style=\"text-align:left\">Compatibility with soft and hard contact lenses<\/li>\n<li style=\"text-align:left\">350+ micro-sized drops per bottle \u2013 the highest number of drops on the market<\/li>\n<li style=\"text-align:left\">Non-blurring formulations<\/li>\n<li style=\"text-align:left\">Patented PureFlow<sup>TM<\/sup> Technology, and blue aiming tip<\/li>\n<li style=\"text-align:left\">Soft sides for easy drop dispensing<\/li>\n<\/ul>\n<p align=\"justify\">Products are available for order by Canadian clinicians at <strong>www.aequuseyecare.ca<\/strong><\/p>\n<p align=\"left\">\n        <strong>About Dry Eye Disease <\/strong>\n      <\/p>\n<p align=\"justify\">Dry eye disease (DED) is a common disorder of the tear film that leads to ocular surface damage over time. Previous research has shown DED reduces health and vision related quality of life and that it carries a considerable economic burden of disease. DED affects approximately 6.3 million Canadians, representing approximately 21% of the population.<sup>1<\/sup> Home confinement, e-learning and working from home due to the COVID-19 pandemic means spending more time looking at screens, which has a significant impact on eye health. A combination of reduced frequency and intensity of blinking during screen time increases the risk of inducing or exacerbating dry eye disease.<sup>2<\/sup><\/p>\n<ol style=\"list-style-type:decimal\">\n<li style=\"margin-bottom:0.95pt;text-align:left\">\n          <em>B. Caffery, S. Srinivasan, C.J. Reaume, et al., Prevalence of dry eye disease in Ontario, Canada: A population-based survey, Ocul. Surf. 17 (2019) 526-531.<\/em>\n        <\/li>\n<li style=\"margin-bottom:0.95pt;text-align:left\">\n          <em>https:\/\/theophthalmologist.com\/covid-19-and-dry-eye-disease<\/em><br \/>\n          <em>; accessed February 24, 2021.<\/em>\n        <\/li>\n<\/ol>\n<p align=\"left\">\n        <strong>About Evolve<\/strong>\n      <\/p>\n<p align=\"justify\">Launched in 2015 in Europe, the Evolve\u00ae brand has grown to 5 products across 35 countries. With an array of products, the brand can address the various symptoms involved with dry eye disease and blepharitis including discomfort, stinging, burning, and dryness. Currently in Canada, the dry eye market is estimated at over $90M, which includes both prescription and over-the-counter products.<\/p>\n<p align=\"left\">\n        <strong>About Aequus Pharmaceuticals Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Aequus Pharmaceuticals Inc. (TSX-V: <a href=\"https:\/\/money.tmx.com\/en\/quote\/AQS\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>AQS<\/u><\/a><a href=\"http:\/\/web.tmxmoney.com\/quote.php?qm_symbol=AQS\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">,<\/a> OTCQB:<a href=\"http:\/\/www.otcmarkets.com\/stock\/AQSZF\/quote\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>AQSZF<\/u>)<\/a> is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its sales and marketing efforts to include several commercial products in ophthalmology and transplant. Aequus plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license; remaining focused on highly specialized therapeutic areas. For further information, please visit<a href=\"http:\/\/www.aequuspharma.ca\/en\/index.htm\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.aequuspharma.ca<\/u>.<\/a><\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statement Disclaimer<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>This release may contain forward-looking statements or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact, including, without limitation, statements containing the words \u201cbelieve\u201d, \u201cmay\u201d, \u201cplan\u201d, \u201cwill\u201d, \u201cestimate\u201d, \u201ccontinue\u201d, \u201canticipate\u201d, \u201cintend\u201d, \u201cexpect\u201d, \u201cpotential\u201d and similar expressions. Forward- looking statements are necessarily based on estimates and assumptions made by us in light of our experience and perception of historical trends, current conditions and expected future developments, as well as the factors we believe are appropriate. Forward-looking statements include but are not limited to statements relating to: the implementation of our business model and strategic plans; revenue growth trends into the future; the rate and degree of market acceptance and clinical utility of our products; the Company\u2019s expected revenues; and the therapeutic benefits, effectiveness and safety of our product candidates and third-party products. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by Aequus, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements. In making the forward looking statements included in this release, the Company has made various material assumptions, including, but not limited to: the manufacturing capacity of third-party manufacturers for our product candidates; our ability to promote and market third party and licensed products; obtaining regulatory approvals; general business and economic conditions; the Company\u2019s ability to successfully out-license or sell its current products and in-license and develop new products; the assumption that the Company\u2019s current good relationships with its manufacturer and other third parties will be maintained; the availability of financing on reasonable terms; the Company\u2019s ability to attract and retain skilled staff; market competition; the products and technology offered by the Company\u2019s competitors; and the Company\u2019s ability to protect patents and proprietary rights. In evaluating forward looking statements, current and prospective shareholders should specifically consider various factors set out herein and under the heading \u201cRisk Factors\u201d in the Company\u2019s Annual Information Form dated April 28, 2020, a copy of which is available on Aequus\u2019 profile on the SEDAR website at www.sedar.com, and as otherwise disclosed from time to time on Aequus\u2019 SEDAR profile. Should one or more of these risks or uncertainties, or a risk that is not currently known to us materialize, or should assumptions underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this release and we do not intend, and do not assume any obligation, to update these forward-looking statements, except as required by applicable securities laws. Investors are cautioned that forward-looking statements are not guarantees of future performance and are inherently uncertain. Accordingly, investors are cautioned not to put undue reliance on forward looking statements. <\/em>\n      <\/p>\n<p align=\"left\">\n        <strong>Contact Information <\/strong><br \/>\n        <br \/>Aequus Investor Relations <br \/>Email: investors@aequuspharma.ca <br \/>Phone: 604-336-7906<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/4ef4686c-723a-403f-8c78-0c135dd01570\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) &#8212; Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (\u201cAequus\u201d or the \u201cCompany\u201d), a Canadian specialty pharmaceutical company announces the commercial availability of EvolveTM preservative free lubricating eye drops for dry eye care. These premium formulations &#8211; \u2018Intensive Daily\u2019 drops, with the gold standard 0.2% sodium hyaluronate, and the unique, triple action \u2018Intensive Gel\u2019 drops, containing hyaluronate, carbomer 980 and glycerol &#8211; will provide soothing hydration and symptom relief for patients with dry eye disease. The products will be available exclusively for sale by eye care clinics in Canada, where patients can receive the full benefit of dry eye treatment plans when they are diagnosed, prescribed, and monitored by eye care professionals. \u201cWe &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-446847","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) &#8212; Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (\u201cAequus\u201d or the \u201cCompany\u201d), a Canadian specialty pharmaceutical company announces the commercial availability of EvolveTM preservative free lubricating eye drops for dry eye care. These premium formulations &#8211; \u2018Intensive Daily\u2019 drops, with the gold standard 0.2% sodium hyaluronate, and the unique, triple action \u2018Intensive Gel\u2019 drops, containing hyaluronate, carbomer 980 and glycerol &#8211; will provide soothing hydration and symptom relief for patients with dry eye disease. The products will be available exclusively for sale by eye care clinics in Canada, where patients can receive the full benefit of dry eye treatment plans when they are diagnosed, prescribed, and monitored by eye care professionals. \u201cWe &hellip; Continue reading &quot;Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-01T13:03:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada\",\"datePublished\":\"2021-03-01T13:03:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/\"},\"wordCount\":1078,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/\",\"name\":\"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=\",\"datePublished\":\"2021-03-01T13:03:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/","og_locale":"en_US","og_type":"article","og_title":"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada - Market Newsdesk","og_description":"VANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) &#8212; Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (\u201cAequus\u201d or the \u201cCompany\u201d), a Canadian specialty pharmaceutical company announces the commercial availability of EvolveTM preservative free lubricating eye drops for dry eye care. These premium formulations &#8211; \u2018Intensive Daily\u2019 drops, with the gold standard 0.2% sodium hyaluronate, and the unique, triple action \u2018Intensive Gel\u2019 drops, containing hyaluronate, carbomer 980 and glycerol &#8211; will provide soothing hydration and symptom relief for patients with dry eye disease. The products will be available exclusively for sale by eye care clinics in Canada, where patients can receive the full benefit of dry eye treatment plans when they are diagnosed, prescribed, and monitored by eye care professionals. \u201cWe &hellip; Continue reading \"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-01T13:03:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada","datePublished":"2021-03-01T13:03:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/"},"wordCount":1078,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/","name":"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=","datePublished":"2021-03-01T13:03:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MTQ4MiMzOTk3Njg2IzIwOTAyMTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-launches-evolve-eyedrops-to-eye-care-professionals-in-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=446847"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446847\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=446847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=446847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=446847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}